WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Artist's creative products bring loved ones closer to the departedGreek athletes excited to attend Chengdu UniversiadeTraveller shares littleIAEA chief calls for maximum restraint over Zaporizhzhia attacksChinese researchers develop immunotherapeutic agent for colon cancerWomen's water polo preliminary at World Aquatics Championships 2023: China vs. AustraliaChina's Qin leads field into men's 50m breaststroke final at Aquatics WorldsEgypt to increase number of aid trucks to warAsian film festival welcomes week of Chinese worksMembers of Team Indonesia attend departure ceremony for Chengdu Universiade